Keyword
in
Collection
Date
to
Houston Voice, No. 903, February 13, 1998
File 008
Citation
MLA
APA
Chicago/Turabian
Houston Voice, No. 903, February 13, 1998 - File 008. 1998-02-13. University of Houston Libraries. University of Houston Digital Library. Web. February 26, 2020. https://digital.lib.uh.edu/collection/montrose/item/1305/show/1275.

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

(1998-02-13). Houston Voice, No. 903, February 13, 1998 - File 008. Montrose Voice. University of Houston Libraries. Retrieved from https://digital.lib.uh.edu/collection/montrose/item/1305/show/1275

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

Houston Voice, No. 903, February 13, 1998 - File 008, 1998-02-13, Montrose Voice, University of Houston Libraries, accessed February 26, 2020, https://digital.lib.uh.edu/collection/montrose/item/1305/show/1275.

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

URL
Embed Image
Compound Item Description
Title Houston Voice, No. 903, February 13, 1998
Contributor
  • Michelak, J. C.
  • Murphy, Terry
Publisher Window Media
Date February 13, 1998
Language English
Subject
  • LGBTQ community
  • LGBTQ people
  • Gay liberation movement
Place
  • Houston, Texas
Genre
  • newspapers
Type
  • Text
Identifier OCLC: 31485329
Collection
  • University of Houston Libraries Special Collections
  • LGBT Research Collection
  • Montrose Voice
Rights In Copyright
Note This item was digitized from materials loaned by the Gulf Coast Archive and Museum (GCAM).
Item Description
Title File 008
Transcript If you are experiencing disease-related weight loss and are finding it difficult to regain the weight, OXANDRIN may be an answer. OXANDRIN is an oral treatment that is available by prescription from your doctor. OXANDRIN helps stimulate the rebuilding of protein tissue in the body and promotes weight gain* OXANDRIN should be used in conjunction with proper nutrition and exercise. Now... a different treatment to help you gain weight To find out more about OXANDRIN, ask your doctor or call 1-800-741-2698. "Since I've been un OXANDRIN, I feel like I have my life back." Jamie f.— An actual person taking OXANDRIN OXANDRIN should be used only as directed by your physician. Precautions and Warnings from the OXANDRIN' (oxandrolone, USP) Clll Package Insert In patients receiving androgenic anabolic steroid therapy, 1) peliosis hepatis, a condition in which the liver and sometimes splenic tissue is replaced with blood-filled cysts, has been reported: 2) liver cell tumois are also reported; 3) blood lipid changes that are Known to be associated with increased risk ot atherosclerosis are seen. See Wimings and Precautions sections of complete presenbing information. CONTRAINDICATIONS: 1) known or suspected carcinoma ol the prostate or the male breast. 2) carcinoma ot the breast in temales with hypercalcemia (androgenic anabolic steroids may stimulate osteolytic bone resorption); 3) pregnancy, because ot possible masculinization of Ihe fetus. Oxandnn has been shown to cause embiyotoxicity. fetotoxicily. infertility, and masculinization of female animal offspring when given in doses 9 times the human dose; 4) nephrosis ot nephrotic phase ol nephritis. 5) hypercalcemia OXA-1635 ©19* BTG Pharmaceuticals. Please see important information on the following page. )X^NDRIN f oxandrolone, usp <jh 2,5 mg tablets The answer to disease-related weight loss* "After weight loss due to extensive surgery, chronic infection, severe trauma, failure to gam or maintain normal weight withoul definite pathophysiologic reasons, or protein catabolism due to prolonged corticosteroid administration. PAGE
File Name uhlib_31485329_n903_007.jpg